|

BL-M08D1 Clinical Trials

2 actively recruiting trials

Pipeline

Phase 1: 2

Top Sponsors

  • Sichuan Baili Pharmaceutical Co., Ltd.2

Indications

  • Cancer2
  • Relapsed or Refractory Lymphoid Malignancies1
  • Solid Tumor1

Other2 trials

A Study of BL-M08D1 in Patients With Locally Advanced or Metastatic Solid Tumors
Phase 1
A Study of BL-M08D1 in Patients With Relapsed or Refractory Lymphoid Malignancies
Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.